Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis

Cancer

Volumn 113, Issue 3, 2008, Pages 522-529

  Inaba, Hiroto ^a,b   Fan, Ying ^a   Pounds, Stanley ^a   Geiger, Terrence L ^a,b   Rubnitz, Jeffrey E ^a,b   Ribeiro, Raul C ^a,b   Pui, Ching Hon ^a,b   Razzouk, Bassem I ^a,b,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c St Vincent Hospital   (United States)

Author keywords

Acute myeloid leukemia; Childhood; Hyperleukocytosis; Leukoreduction

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ANURIA; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILD CARE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROLYTE DISTURBANCE; EXCHANGE BLOOD TRANSFUSION; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPERKALEMIA; HYPERLEUKOCYTOSIS; HYPERPHOSPHATEMIA; HYPERURICEMIA; HYPOCALCEMIA; HYPOXIA; INFANT; INFECTION; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; NEUROLOGIC DISEASE; NEWBORN; OLIGURIA; PRIORITY JOURNAL; TACHYPNEA; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTOSIS; MALE; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 49049084232     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23581     Document Type: Article

References (25)

1. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39:1-18.
2. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22:4384-4393.
3. Riley LC, Hann IM, Wheatley K, Stevens RF. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party. Br J Haematol. 1999;106:436-444.
4. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute non-lymphoblastic leukemia. J Clin Oncol. 1985;3:1590-1595.
5. Creutzig U, Ritter J, Budde M, Sutor A, Schellong G. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia. Cancer. 1987;60:3071-3079.
6. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol. 1987;5:1364-1372.
7. Hug V, Keating M, McCredie K, Hester J, Bodey GP, Freireich EJ. Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer. 1983;52:773-779.
8. Bunin NJ, Kunkel K, Callihan TR. Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children. Med Pediatr Oncol. 1987;15:232-235.
9. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol. 1997;98:433-436.
10. Ribeiro RC, Razzouk BI, Pounds S, Hijiya N, Pui CH, Rubnitz JE. Successive clinical trials for childhood acute myeloid leukemia at St. Jude Children's Research Hospital, from 1980 to 2000. Leukemia. 2005;19:2125-2129.
11. Lowe EJ, Pui CH, Hancock ML, Geiger TL, Khan RB, Sandlund JT. Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer. 2005;45:10-15.
12. Moses LE. Query: confidence limits from rank tests. Technometrics. 1965;7:757-760.
13. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1-39.
14. Lightman MA. Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. Possible relationship to clinical manifestations. J Clin Invest. 1973;52:350-358.
15. Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood. 2001;97:2121-2129.
16. Harris AL. Leukostasis associated with blood transfusion in acute myeloid leukaemia. BMJ. 1978;1:1169-1171.
17. Tobelem G, Jacquillat C, Chastang C, et al. Acute monoblastic leukemia: a clinical and biologic study of 74 cases. Blood. 1980;55:71-76.
18. Hijiya N, Metzger ML, Pounds S, et al. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia. Pediatr Blood Cancer. 2005;44:63-69.
19. Zarkovic M, Kwaan HC. Correction of hyperviscosity by apheresis. Semin Thromb Hemost. 2003;29:535-542.
20. Thiebaut A, Thomas X, Belhabri A, Anglaret B, Archimbaud E. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol. 2000;79:501-506.
21. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18:2327-2340.
22. Vaughan WP, Kimball AW, Karp JE, Dragon LH, Burke PJ. Factors affecting survival of patients with acute myelocytic leukemia presenting with high WBC counts. Cancer Treat Rep. 1981;65:1007-1013.
23. Kotelnikov VM, Kasatkina VV, Dultsina SM, et al. Effects of cytapheresis on cell cycle distribution of peripheral blood and bone marrow cells in some hematological malignancies. Leukemia Res. 1987;11:397-403.
24. Kiyoi H, Naoe T, Nakano Y, et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood. 1999;93:3074-3080.
25. Meshinchi S, Woods WG, Stirewalt DL, et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood. 2001;97:89-94.